Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 400

1.

Circulating tumor cells as promising novel biomarkers in solid cancers.

Lianidou ES, Strati A, Markou A.

Crit Rev Clin Lab Sci. 2014 Jun;51(3):160-71. doi: 10.3109/10408363.2014.896316. Epub 2014 Mar 19. Review.

PMID:
24641350
2.

The Role of CTCs as Tumor Biomarkers.

Lianidou ES, Markou A, Strati A.

Adv Exp Med Biol. 2015;867:341-67. doi: 10.1007/978-94-017-7215-0_21. Review.

PMID:
26530376
3.

Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges.

Lianidou ES, Markou A.

Clin Chem. 2011 Sep;57(9):1242-55. doi: 10.1373/clinchem.2011.165068. Epub 2011 Jul 22. Review.

4.

Clinical challenges in the molecular characterization of circulating tumour cells in breast cancer.

Lianidou ES, Mavroudis D, Georgoulias V.

Br J Cancer. 2013 Jun 25;108(12):2426-32. doi: 10.1038/bjc.2013.265. Epub 2013 Jun 11. Review.

5.

Organ-specific markers in circulating tumor cell screening: an early indicator of metastasis-capable malignancy.

Paterlini-Bréchot P.

Future Oncol. 2011 Jul;7(7):849-71. doi: 10.2217/fon.11.32. Review.

PMID:
21732757
6.

Circulating tumor cells in lung cancer.

Young R, Pailler E, Billiot F, Drusch F, Barthelemy A, Oulhen M, Besse B, Soria JC, Farace F, Vielh P.

Acta Cytol. 2012;56(6):655-60. doi: 10.1159/000345182. Epub 2012 Nov 24. Review.

PMID:
23207444
7.

What's new on circulating tumor cells? A meeting report.

Lianidou ES, Mavroudis D, Sotiropoulou G, Agelaki S, Pantel K.

Breast Cancer Res. 2010;12(4):307. doi: 10.1186/bcr2601. Epub 2010 Jul 23.

8.

Circulating tumor cells: liquid biopsy of cancer.

Alix-Panabières C, Pantel K.

Clin Chem. 2013 Jan;59(1):110-8. doi: 10.1373/clinchem.2012.194258. Epub 2012 Sep 26. Review.

9.

Towards a personalized breast cancer treatment approach guided by circulating tumor cell (CTC) characteristics.

Onstenk W, Gratama JW, Foekens JA, Sleijfer S.

Cancer Treat Rev. 2013 Nov;39(7):691-700. doi: 10.1016/j.ctrv.2013.04.001. Epub 2013 May 16. Review.

PMID:
23683721
10.

Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications.

Danova M, Torchio M, Mazzini G.

Expert Rev Mol Diagn. 2011 Jun;11(5):473-85. doi: 10.1586/ERM.11.33. Review.

PMID:
21707456
11.

Circulating tumor cells: a multifunctional biomarker.

Yap TA, Lorente D, Omlin A, Olmos D, de Bono JS.

Clin Cancer Res. 2014 May 15;20(10):2553-68. doi: 10.1158/1078-0432.CCR-13-2664. Review.

12.

Isolation of rare circulating tumour cells in cancer patients by microchip technology.

Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky A, Ryan P, Balis UJ, Tompkins RG, Haber DA, Toner M.

Nature. 2007 Dec 20;450(7173):1235-9.

13.

Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer.

O'Flaherty JD, Gray S, Richard D, Fennell D, O'Leary JJ, Blackhall FH, O'Byrne KJ.

Lung Cancer. 2012 Apr;76(1):19-25. doi: 10.1016/j.lungcan.2011.10.018. Epub 2011 Dec 29. Review.

PMID:
22209049
14.

[Circulating tumor cells: liquid biopsy].

Alix-Panabières C, Pierga JY.

Bull Cancer. 2014 Jan 1;101(1):17-23. doi: 10.1684/bdc.2014.1883. Review. French.

PMID:
24445939
15.

Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patients.

Fischer JC, Niederacher D, Topp SA, Honisch E, Schumacher S, Schmitz N, Zacarias Föhrding L, Vay C, Hoffmann I, Kasprowicz NS, Hepp PG, Mohrmann S, Nitz U, Stresemann A, Krahn T, Henze T, Griebsch E, Raba K, Rox JM, Wenzel F, Sproll C, Janni W, Fehm T, Klein CA, Knoefel WT, Stoecklein NH.

Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):16580-5. doi: 10.1073/pnas.1313594110. Epub 2013 Sep 24.

16.

[Disseminated and circulating tumor cells in gastrointestinal oncology].

Vegas H, André T, Bidard FC, Ferrand FR, Huguet F, Mariani P, Pierga JY.

Bull Cancer. 2012 May;99(5):535-44. doi: 10.1684/bdc.2012.1581. Review. French.

17.

Nanostructure embedded microchips for detection, isolation, and characterization of circulating tumor cells.

Lin M, Chen JF, Lu YT, Zhang Y, Song J, Hou S, Ke Z, Tseng HR.

Acc Chem Res. 2014 Oct 21;47(10):2941-50. doi: 10.1021/ar5001617. Epub 2014 Aug 11. Review.

18.

Circulating tumor cells as therapy-related biomarkers in cancer patients.

Gorges TM, Pantel K.

Cancer Immunol Immunother. 2013 May;62(5):931-9. doi: 10.1007/s00262-012-1387-1. Epub 2013 Jan 12. Review.

PMID:
23314304
19.

Circulating tumor cells (CTCs) as a liquid biopsy material and drug target.

Cai LL, Ye HM, Zheng LM, Ruan RS, Tzeng CM.

Curr Drug Targets. 2014;15(10):965-72.

PMID:
25182470
20.

Global gene expression profiling of circulating tumor cells.

Smirnov DA, Zweitzig DR, Foulk BW, Miller MC, Doyle GV, Pienta KJ, Meropol NJ, Weiner LM, Cohen SJ, Moreno JG, Connelly MC, Terstappen LW, O'Hara SM.

Cancer Res. 2005 Jun 15;65(12):4993-7.

Supplemental Content

Support Center